Market Overview - The secondary market for publicly listed REITs in China showed an overall downward trend, with the weighted REITs index closing at 143.24 and a weekly return of -1.22% [2] - In comparison to other major asset classes, the return rates ranked from high to low are: convertible bonds, US stocks, A-shares, pure bonds, REITs, gold, and crude oil [2] - Among different project attributes, both property and concession REITs experienced price declines, with property REITs showing a smaller drop [2] - The transportation infrastructure REITs had the largest decline, while the top three performing asset types were affordable housing, energy, and ecological protection [2] Trading Activity - The total trading volume for publicly listed REITs was 2.9 billion yuan, with municipal facility REITs leading in average daily turnover rate [3] - The average daily turnover rate for all listed REITs was 0.93% [3] - The top three REITs by trading volume were Guotai Junan Dongjiu New Economy REIT, Zhongjin ProLogis REIT, and Huaxia China Communications Construction REIT [3] Net Inflow and Block Trading - The total net inflow for the week was 81.54 million yuan, indicating a decrease in market trading enthusiasm [4] - The top three asset types for net inflow were consumer infrastructure, park infrastructure, and energy infrastructure [4] - The total amount of block trading reached 789.97 million yuan, significantly higher than the previous week, with the highest single-day block trading occurring on June 24, 2025, at 309.6 million yuan [4] New Listings - Two new REITs were listed this week: Zhongjin Yizhuang Industrial Park REIT on June 26, 2025, and Zhongjin China Green Development Commercial Asset REIT on June 27, 2025 [5]

以下文章来源于债券人 ，作者光大证券固收研究 债券人 . 唯有进行扎实的基本面研究，方能行稳致远。 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 点击注册小程序 报告摘要 查看完整报告 特别申明： 1、市场行情 本周（2025年6月23日至2025年6月27日，共5个交易日）转债市场显著上涨，全周中证转债指数涨跌幅为 +2.1%（上一交易周为-0.2%），周内涨幅创年内最高；本周中证全指变动为+3.3%。2025年开年以来，中 证转债涨跌幅为+6.6%，中证全指数涨跌幅为+3.4%，转债市场表现好于权益市场。 分评级来看，高评级券（评级为AA+及以上）、中评级券（评级为AA）、低评级券（评级为AA-及以下） 本周涨跌幅分别为+1.75%、+2.47%、+2.78%，低评级券本周涨幅最多。分转债规模看，大规模转债（债 券余额 ...

Group 1 - The company has announced a restricted stock incentive plan for 2025, granting 5 million shares at a price of 95 yuan per share to 1,368 individuals, representing 0.61% of the total share capital at the time of the announcement [2] - The incentive plan's assessment period is set from 2025 to 2027, with revenue growth targets of 20.00%, 44.00%, and 72.80% for the respective years, based on the 2024 revenue as a baseline [3] - The expected amortization expenses for the stock incentive plan from 2025 to 2028 are projected to be 57.34 million, 87.30 million, 44.76 million, and 14.80 million yuan respectively [3] Group 2 - The company has invested 2.261 billion yuan in R&D in 2024, accounting for 21.95% of its revenue, indicating a strong commitment to innovation [4] - The company has launched several strategic innovative products, including the uLinacHalosTx precision radiotherapy system and the uMR Max 3.0T MRI, which are expected to enhance its competitive position [4] - The domestic medical imaging equipment bidding market is projected to grow by 100.36% year-on-year from January to May 2025, suggesting a potential improvement in the company's performance as the market recovers [4]

Core Viewpoint - The company is adjusting its customer success service packages and pricing, which is expected to positively impact its gross profit by differentiating between standard and advanced services, allowing for increased contract revenue from large enterprise clients while reducing implementation costs for standard package clients [2]. Group 1: Service Adjustments - Starting from July 1, 2025, the company will no longer include ticket services in the standard success service package, requiring clients to purchase the advanced service for an additional cost of 15% of the software subscription amount [2]. - This adjustment aims to enhance the distinction between standard and customized services, potentially increasing revenue during contract renewals with large enterprise clients [2]. Group 2: Product Launches - The company has launched the upgraded Cangqiong Agent Platform 2.0, which integrates deeply with core business systems like ERP through the MCP standard protocol [3]. - Five intelligent agents have been developed on this platform, including: 1. JinYao Financial Report Agent for deep financial report analysis and synthesis [3]. 2. ChatBI for data exploration through natural language queries [3]. 3. Recruitment Agent for automating the hiring process, improving matching accuracy from 40% to 90% [3]. 4. Travel Agent for automating travel arrangements based on user preferences [3]. 5. Enterprise Knowledge Agent for intelligent decision-making based on company-specific knowledge [3]. - As of May 2025, the platform has signed contracts with 20 clients, including Hisense Group and Wens Foodstuff Group [3]. Group 3: Revenue Performance - In 2024, the company generated revenue of 1.304 billion RMB from large enterprise clients, a year-on-year increase of 32.9%, with contract signing amounts reaching approximately 2.1 billion RMB, up 52% [4]. - Revenue from medium-sized clients was 2.153 billion RMB, reflecting a growth of 10.3%, while small and micro business revenue reached 1.229 billion RMB, growing by 13.8% [4]. - The company anticipates steady growth in large enterprise business for 2025, although medium and small business segments may face challenges due to macroeconomic conditions [4].

Core Viewpoint - The company anticipates gradual improvement in performance in Q2 2025 and the second half of the year, following the end of inventory destocking by downstream customers in the home respiratory device component sector [3]. Group 1: Home Respiratory Devices and Cochlear Implants - The company's core business involves the development, manufacturing, and sales of home respiratory devices and cochlear implant components [3]. - In 2024, the company expects a return to normal growth rates for home respiratory device component orders, supported by the Malaysian base potentially avoiding tariff risks, which is expected to drive long-term revenue growth [3]. - Revenue from cochlear implant components is showing steady growth, and new product component revenues are rapidly increasing, indicating effective diversification in business segments [3]. - Due to the impact of the Spring Festival on Q1 2025, revenue growth has slowed compared to the full year of 2024, but performance is expected to improve gradually as order deliveries resume [3]. Group 2: Blood Glucose Management and Production Expansion - The company has made breakthroughs in core technologies such as precision molds and liquid silicone, focusing on products like disposable injection pens, continuous glucose monitoring (CGM) devices, and insulin patch pumps [4]. - Collaborations with global medical device leaders are ongoing in the fields of blood glucose management, IVD diagnostics, and cardiovascular devices [4]. - A fully automated production project for insulin injection pens developed for international clients has achieved large-scale production in 2024 [4]. - The company has completed the core R&D work for its self-designed "Beautiful Pen," which includes three major technology directions [4]. - The Malaysian production base has successfully completed the first two phases of capacity construction, with the third phase expected to be operational by the end of 2025 [4]. Group 3: Stock Incentive Plan - The company has announced a stock incentive plan for 2025, granting a total of 5 million shares to no more than 304 core employees, representing 1.23% of the total share capital [5]. - The performance assessment for the stock incentive plan is based on revenue or net profit for 2023, with target growth rates for 2025-2027 set at no less than 56.25%, 95.31%, and 144.14% respectively [5]. - The triggering growth rates for 2025-2027 are set at no less than 44.00%, 72.80%, and 107.36% respectively, reflecting the company's confidence in long-term growth [5].

Core Viewpoint - The company is undergoing a transformation towards strategic emerging industries, particularly focusing on hydrogen energy and equipment manufacturing, while also benefiting from the ongoing state-owned enterprise reform in Shanxi Province [5][7][8]. Group 1: Shareholder Actions - The controlling shareholder, Shanxi Luan Chemical Co., Ltd., increased its stake in the company by purchasing 2.1 million shares, representing 0.09% of the total share capital, for a total of 5 million yuan [2]. - The controlling shareholder plans to invest between 50 million yuan and 100 million yuan in the company over the next 12 months, aiming to acquire up to 2% of the total share capital [4]. Group 2: Company Name Change - The company has proposed to change its name to Shanxi Luan Chemical Technology Co., Ltd. and its stock abbreviation to Luanhua Technology, pending approval from the shareholders' meeting [3]. Group 3: Strategic Transition - The company is transitioning towards strategic emerging industries, with a strong emphasis on hydrogen energy and equipment manufacturing, following the completion of the controlling shareholder change in December 2024 [5]. - The company has been phasing out outdated production capacity in response to government policies, which aligns with its new strategic direction [5]. Group 4: Benefits from State-Owned Enterprise Reform - The ongoing state-owned enterprise reform in Shanxi Province is expected to enhance governance efficiency and business optimization for the company, which is a state-owned enterprise [7]. - As of November 2024, the reform progress in Shanxi has exceeded 65%, with plans to complete 70% of the main tasks by the end of the year [7]. Group 5: Synergies with Controlling Shareholder - The controlling shareholder, Luan Chemical, is one of the four major state-owned energy groups in Shanxi, involved in various sectors including chemicals, coal, and clean energy [8]. - The company is expected to leverage the successful experiences of its controlling shareholder to drive high-quality development through smart and digital transformation in its core chemical and hydrogen energy businesses [8].

Group 1 - The main variable in the funding landscape is passive and individual funds, with public funds being the most elastic institutional capital, primarily driven by passive funds [3] - Future changes in public fund flows are expected to focus on institutional increases in broad index ETFs, with indices like CSI 300, SSE 50, and STAR 50 likely to see significant upward movement driven by capital [3] - Individual funds remain a crucial source of capital in thematic market trends, and once market upward expectations align, individual funds are anticipated to provide strong ongoing incremental capital [3]

Core Viewpoint - Stablecoins are positioned as "digital cash" in the blockchain era, providing price stability through pegging to fiat currencies, commodities, or other assets, with applications in cryptocurrency trading, cross-border payments, and RWA transactions [2] Group 1: Market Overview - As of June 26, 2025, the total market capitalization of stablecoins is approximately $252.6 billion, with USDT and USDC together accounting for 87% of this total, valued at $157.9 billion and $61.4 billion respectively [3] Group 2: Profit Models - The profit model for fiat-collateralized stablecoins primarily relies on the management of reserve asset returns. Tether's reserves allocate 80% to cash or cash-like assets (mostly U.S. Treasury bonds) and 20% to Bitcoin and gold, while Circle's reserves consist of about 10% cash and 90% in short-term U.S. Treasury bonds or repurchase agreements. In 2024, Tether and Circle achieved net profits of $13 billion and $156 million respectively [4] Group 3: Regulatory Developments - Significant legislation has been passed, propelling stablecoins into a compliance-driven development phase. The U.S. "GENIUS Act" establishes a strict regulatory framework for stablecoin issuance, including issuer limitations and reserve asset requirements, and was passed in the Senate with a vote of 68 to 30 on June 17, 2025. Additionally, Hong Kong's Legislative Council passed the "Stablecoin Ordinance" requiring institutions issuing or promoting HKD stablecoins to obtain licenses with stringent standards [5] Group 4: Strategic Roles in Finance - The core of the "GENIUS Act" mandates that stablecoins must be 100% backed by U.S. dollar cash or high liquidity assets like short-term U.S. Treasury bonds, and issued by licensed entities. This creates a structural demand for U.S. Treasuries, shifting the holders from sovereign entities to ordinary users. In contrast, Hong Kong's regulations emphasize stablecoins as payment tools, contributing to the internationalization of the Renminbi, which has seen a notable increase in its share within the SWIFT cross-border settlement system and foreign exchange reserves [6]

Group 1: Real Estate - The land auction heat in core cities continues, with the average transaction price of residential land in 30 core cities increasing by 24% year-on-year from January to May 2025 [4] - From January to May, the total area of residential land sold in 100 cities was 69.91 million square meters, a decrease of 3.4% year-on-year, with an average floor price of 7,466 yuan per square meter, up 26.2% year-on-year [4] - In May, the overall premium rate for residential land transactions in the 30 core cities was 9.2%, an increase of 7.1 percentage points year-on-year, with 15 plots exceeding a premium rate of 20% [4] - The top 50 real estate companies saw a 42% year-on-year increase in the value of newly acquired land reserves, while the area of new land reserves decreased by 1% year-on-year [4] - The high-energy cities' real estate market is expected to gradually stabilize after a period of decline [4] Group 2: Metals and New Materials - The price of iridium reached a nearly 10-month high, while the price of polysilicon hit a new low since 2014 [4] - Prices for military new materials remained stable, while lithium hydroxide prices decreased in the new energy vehicle sector [4] - Polysilicon prices have dropped, and uranium prices have increased in the nuclear power new materials sector [4] - The price of high-purity gallium fell in the consumer electronics new materials sector, and platinum prices also decreased [4] - Lithium prices have dropped to around 60,000 yuan per ton, with the potential for accelerated capacity exit in the future; companies with cost advantages and resource expansion in the lithium mining sector are recommended for attention [4]

Core Viewpoint - The real estate market in China is experiencing mixed trends, with a decline in land transaction area but an increase in land price per square meter, indicating a potential shift in market dynamics and investment opportunities [3][4]. Group 1: Land Transaction Data - In the first five months of 2025, the total area of residential land transactions in 100 cities decreased by 3.4% year-on-year, while the average transaction price per square meter increased by 26.2% [3]. - For first-tier cities, the supply of residential land was 464 million square meters, up 5.3% year-on-year, but the transaction area fell by 12.6%, with an average price of 42,605 yuan per square meter, up 50.6% year-on-year [3]. - In second-tier cities, the supply of residential land was 4,105 million square meters, down 2.9%, while the transaction area increased by 7.1%, with an average price of 8,735 yuan per square meter, up 19.1% year-on-year [3]. - Third-tier cities saw a significant decline in supply, with a 27.8% drop in residential land area, and a 10.6% decrease in transaction area, while the average price rose by 14.1% to 3,233 yuan per square meter [3]. Group 2: Top 50 Real Estate Companies - The top 50 real estate companies in China reported a 42% year-on-year increase in the value of newly acquired land reserves, totaling 421.8 billion yuan, with Poly Developments leading at 41.3 billion yuan [4]. - The total area of newly acquired land reserves by these companies decreased by 1.2% year-on-year, amounting to 30.92 million square meters, with Greentown China acquiring the largest area at 1.85 million square meters [4]. Group 3: Market Trends in May 2025 - In May 2025, the overall premium rate for land transactions in 30 core cities was 9.2%, an increase of 7.1 percentage points year-on-year, with a total of 91 land parcels sold, reflecting a 89.6% increase year-on-year [5]. - The total area of land transactions in these cities reached 6.67 million square meters, up 64.3% year-on-year, with a total transaction value of 62.3 billion yuan, up 78.3% year-on-year [5]. - The average transaction price per square meter in May was 9,342 yuan, reflecting an 8.5% increase year-on-year [5]. Group 4: Specific Land Transactions - Notable land transactions in May included a plot in Wenzhou acquired by Zhongjie Real Estate at a price of 5,484 yuan per square meter with a premium rate of 72%, and a plot in Chengdu acquired at 7,250 yuan per square meter with a premium rate of 59.3% [6]. - The total number of land transactions in the 30 core cities from January to May was 491, with a cumulative area of 34.4 million square meters, up 15.6% year-on-year, and a total transaction value of 431.7 billion yuan, up 43.2% year-on-year [6].